Company: AEMD
Filing Date: 2025-09-09
Form Type: 8-K
Source: 0001683168-25-006788
Chunk: 0

Company: AETHLON MEDICAL INC
Filing Date: 2025-09-09
Form: 8-K
Item: Item 1.01
Chunk 0
---
Item 1.01 Entry into a Material Definitive
Agreement

On September 4, 2025,
Aethlon Medical, Inc., a Nevada corporation (the “ Company”), entered into a Securities Purchase Agreement (the “ Purchase
Agreement”) with certain investors (the “ Investors”), pursuant to which the Company agreed to sell, issue, and deliver,
in a registered public offering (the “ Offering”) (i) 4,047,780 shares (“ Shares”) of common stock, par value $0.001
per share (the “ Common Stock”), (ii) 5,000,000 warrants to purchase up to 5,000,000 shares of Common Stock (the “ Common
Warrants”), (iii) 952,220 Pre-Funded Warrants to purchase up to 952,220 shares of Common Stock (the “ Pre-Funded Warrants”),
(iv) 200,000 warrants to purchase up to 200,000 shares of Common Stock (the “ Placement Agent Warrants”, and together with
the Pre-Funded Warrants and Common Warrants, the “ Warrants”).

Under the terms of the
Purchase Agreement, the Company agreed to sell one share of its Common Stock or a Pre-Funded Warrant in lieu thereof, together with one
Common Warrant (collectively, a “ Common Unit”) sold in the Offering at a combined public offering price of $0.90 per Common
Unit.

The Common Warrants are
exercisable immediately upon issuance and have an exercise price of $0.90 per share, subject to adjustment as set forth therein.

The Offering closed on
September 5, 2025. The securities were registered pursuant to the registration statement, on Form S-1 (File No. 333-289745), which was
initially filed with the Securities and Exchange Commission (the “ Commission”) on August 20, 2025, and amended on August 29,
2025, which the Commission declared effective on September 4, 2025.

Maxim Group LLC acted
as the exclusive placement agent (the “ Placement Agent”) in connection with the Offering. On September 4, 2025, the Company
and the Placement Agent entered into a Placement Agency Agreement (the “ Placement Agency Agreement”), pursuant to which, as
compensation for services rendered by the Placement Agent in connection with the Offering, the Company agreed to pay the Placement Agent
an aggregate cash fee of 6.25